278 related articles for article (PubMed ID: 34133836)
1. SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth.
Dhurat R; Daruwalla S; Pai S; Kovacevic M; McCoy J; Shapiro J; Sinclair R; Vano-Galvan S; Goren A
J Cosmet Dermatol; 2022 Jan; 21(1):343-346. PubMed ID: 34133836
[TBL] [Abstract][Full Text] [Related]
2. Minoxidil sulfotransferase enzymatical activity in plants: A novel paradigm in increasing minoxidil response in androgenetic alopecia.
Mehta N; Huang S; Dhura R; Wambier C; do Nascimento Fonesca D; Little S; Goren A
J Cosmet Dermatol; 2024 Jan; 23(1):339-343. PubMed ID: 37638619
[TBL] [Abstract][Full Text] [Related]
3. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia.
Goren A; Castano JA; McCoy J; Bermudez F; Lotti T
Dermatol Ther; 2014; 27(3):171-3. PubMed ID: 24283387
[TBL] [Abstract][Full Text] [Related]
4. Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants predicts response to oral minoxidil treatment for female pattern hair loss.
Ramos PM; Gohad P; McCoy J; Wambier C; Goren A
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e24-e26. PubMed ID: 32567076
[No Abstract] [Full Text] [Related]
5. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
Roberts J; Desai N; McCoy J; Goren A
Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
7. Minoxidil: a comprehensive review.
Gupta AK; Talukder M; Venkataraman M; Bamimore MA
J Dermatolog Treat; 2022 Jun; 33(4):1896-1906. PubMed ID: 34159872
[TBL] [Abstract][Full Text] [Related]
8. Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients.
Goren A; Sharma A; Dhurat R; Shapiro J; Sinclair R; Situm M; Kovacevic M; Lukinovic Skudar V; Goldust M; Lotti T; McCoy J
Dermatol Ther; 2018 Nov; 31(6):e12741. PubMed ID: 30226287
[TBL] [Abstract][Full Text] [Related]
9. Doppler laser imaging predicts response to topical minoxidil in the treatment of female pattern hair loss.
McCoy J; Kovacevic M; Situm M; Stanimirovic A; Bolanca Z; Goren A
J Biol Regul Homeost Agents; 2016; 30(1):131-4. PubMed ID: 27049083
[TBL] [Abstract][Full Text] [Related]
10. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes.
Sharma A; Goren A; Dhurat R; Agrawal S; Sinclair R; Trüeb RM; Vañó-Galván S; Chen G; Tan Y; Kovacevic M; Situm M; McCoy J
Dermatol Ther; 2019 May; 32(3):e12915. PubMed ID: 30974011
[TBL] [Abstract][Full Text] [Related]
11. Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia.
Faghihi G; Iraji F; Siadat AH; Saber M; Jelvan M; Hoseyni MS
J Cosmet Dermatol; 2022 Oct; 21(10):4447-4453. PubMed ID: 35152531
[TBL] [Abstract][Full Text] [Related]
12. Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review.
Pietrauszka K; Bergler-Czop B
Postepy Dermatol Alergol; 2022 Jun; 39(3):472-478. PubMed ID: 35950120
[TBL] [Abstract][Full Text] [Related]
13. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Suchonwanit P; Rojhirunsakool S; Khunkhet S
Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
[TBL] [Abstract][Full Text] [Related]
14. Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response.
Ramos PM; McCoy J; Wambier C; Shapiro J; Vañó-Galvan S; Sinclair R; Goren A
J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):e799-e800. PubMed ID: 32432358
[No Abstract] [Full Text] [Related]
15. Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia.
Bao L; Gong L; Guo M; Liu T; Shi A; Zong H; Xu X; Chen H; Gao X; Li Y
J Cosmet Laser Ther; 2020; 22(1):1-7. PubMed ID: 29028377
[No Abstract] [Full Text] [Related]
16. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
17. The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity.
Goren A; Mccoy J; Kovacevic M; Situm M; Chitalia J; Dhurat R; Naccarato T; Lotti T
J Biol Regul Homeost Agents; 2018; 32(4):937-940. PubMed ID: 30043580
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
[TBL] [Abstract][Full Text] [Related]
20. Topical minoxidil for hair regrowth.
Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
